Abaloparatide will be available in England within three months for more than 14,000 postmenopausal women
More than 14,000 postmenopausal women in England could benefit from a new drug that helps prevent bone fractures.
Osteoporosis weakens bones and affects 3.8 million people in the UK. It particularly affects older women because during the menopause oestrogen, the hormone that is important for maintaining bone density and strength, decreases and bone density reduces.
